TELA Bio (TELA) Operating Income Growth (3y) (2021 - 2026)
TELA Bio (TELA) Operating Income Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 13.06% |
| 10 | TELA Bio | 36.75 Mn | 6.32 Mn | 13.94 Mn | 3.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.60% |
| Mar 31, 2026 | 2.20% |
| Dec 31, 2025 | 11.03% |
| Sep 30, 2025 | 7.31% |
| Jun 30, 2025 | 3.92% |
| Mar 31, 2025 | -2.08% |
| Dec 31, 2024 | -2.96% |
| Sep 30, 2024 | -9.07% |
| Jun 30, 2024 | -16.53% |
| Mar 31, 2024 | 12.76% |
| Dec 31, 2023 | -22.09% |
| Sep 30, 2023 | -14.05% |
| Jun 30, 2023 | -26.11% |
| Mar 31, 2023 | -20.08% |
| Dec 31, 2022 | -17.45% |
| Sep 30, 2022 | -35.00% |
| Jun 30, 2022 | -33.53% |
| Mar 31, 2022 | -23.86% |
| Dec 31, 2021 | -11.66% |
| Sep 30, 2021 | -41.93% |